The Asthma and Allergy Foundation of America (AAFA) is deeply concerned about recent federal actions and congressional budget threats that could put millions of Americans with asthma and allergies at risk. These policy changes jeopardize access to essential health care, environmental protections, and disability accommodations—critical safeguards for the over 100 million people in the U.S. living with asthma and/or allergic diseases. Ensuring access to quality health care, clean air, and safe ..read more

Experts develop standard definition and educational tools for health care professionals Anaphylaxis: a serious allergic reaction that can progress rapidly and may cause death. It may involve these systems: Skin/mucosa (includes lip, tongue) Respiratory (lungs, breathing) Cardiovascular (heart, blood pressure), and/or Gastrointestinal (stomach, gut) Life threatening anaphylaxis is characterized by respiratory and/or cardiovascular involvement and may occur without skin/mucosa involvement ..read more

Update as of Feb. 21, 2025: The 17 states involved in the lawsuit filed a joint status statement claiming they don’t intend to strike down Section 504 entirely, but this has not changed the scope of the case. The lawsuit has not been amended, and the original constitutional challenge to Section 504 has not been withdrawn. This means the threat to 504 plans for students with asthma and food allergies still exists. Until the complaint is officially amended or withdrawn, advocates must keep up ..read more

Welcome to our February research update! Getting involved with research is an important way to impact asthma and allergy treatments, education, and awareness. This month, we are highlighting clinical trials, surveys, and news on: Eosinophilic asthma Nasal polyps Respiratory syncytial virus (RSV) Allergic rhinitis (hay fever) treatments Montelukast and children’s mental health Antibiotics and asthma Biologics for asthma Asthma caregivers’ quality of life Note: The links below will take you to ..read more

Asthma is a chronic (long-term) disease that causes inflammation and swelling of your airways. Nasal polyps are soft tissue growths on the lining inside the nose and sinuses. While they seem very different, they are actually related. What Do Nasal Polyps and Asthma Have in Common? Both asthma and nasal polyps are caused by something called type 2 inflammation. Type 2 inflammation is a type of immune response. This type of response happens when your body senses an intruder like an infection ..read more

Class 2 Device Recall NasoGel Spray For Immediate Release February 05, 2025 Contact Information Mr. Srikanth Pai 707-525-3784 Company Announcement On 12/28/2024, the firm sent an "URGENT: MEDICAL DEVICE RECALL" Letter to customers informing them that firm is conduct a voluntary recall due to a microbial failure found during routine stability testing and the receipt of complaints (11 reports) related to the products unpleasant odor. Through investigation, this has led to the recall of 3 lots ..read more

Join the Asthma and Allergy Foundation of America (AAFA) in celebrating Black History Month. In February, we take the time to reflect and celebrate the achievements of Black people in the United States throughout this nation’s history. Our Black communities and leadership across this nation continue to innovate, advocate for, and lead major efforts in improving the health of people living with asthma, allergies, and allergic conditions. While honoring the progress made, AAFA continues to ..read more

Reducing exposure to triggers and allergens is a critical part of controlling asthma and allergy symptoms. And many products promise to help improve indoor air quality and reduce your exposure to asthma and allergy triggers. But some products make false or exaggerated claims. This makes it hard for people to know the best products to use. AAFA joined with Allergy Standards Limited (ASL) to create the  Asthma & Allergy Friendly® Certification Program. We independently test household ..read more

Asthma and Allergy Foundation of America Reaffirms Commitment to Protect Vulnerable Communities On behalf of over 100 million people in the United States with asthma and allergic diseases, the Asthma and Allergy Foundation of America (AAFA) is carefully monitoring and evaluating policy transitions that may affect our community’s health. Asthma and allergies are chronic and potentially life-threatening conditions affecting almost every household: nearly 1 in 3 adults and more than 1 in 4 U.S ..read more

Welcome to our January research update! Getting involved with research is an important way to impact asthma and allergy treatments, education, and awareness. This month, we are highlighting clinical trials, surveys, and news on: Asthma Asthma medicine costs Respiratory viruses like respiratory syncytial virus (RSV) and human rhinovirus (HRV) Insect allergy Solar urticaria Link between viral respiratory infections and asthma risk in childhood Pulse oximeters in various skin tones Note: The ..read more